1. Home
  2. PHAR vs SNCY Comparison

PHAR vs SNCY Comparison

Compare PHAR & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • SNCY
  • Stock Information
  • Founded
  • PHAR 1988
  • SNCY 1982
  • Country
  • PHAR Netherlands
  • SNCY United States
  • Employees
  • PHAR N/A
  • SNCY N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • SNCY Air Freight/Delivery Services
  • Sector
  • PHAR Health Care
  • SNCY Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • SNCY Nasdaq
  • Market Cap
  • PHAR 627.5M
  • SNCY 558.2M
  • IPO Year
  • PHAR N/A
  • SNCY 2021
  • Fundamental
  • Price
  • PHAR $8.58
  • SNCY $15.06
  • Analyst Decision
  • PHAR Strong Buy
  • SNCY Buy
  • Analyst Count
  • PHAR 3
  • SNCY 6
  • Target Price
  • PHAR $27.00
  • SNCY $18.33
  • AVG Volume (30 Days)
  • PHAR 7.3K
  • SNCY 694.1K
  • Earning Date
  • PHAR 10-24-2024
  • SNCY 01-29-2025
  • Dividend Yield
  • PHAR N/A
  • SNCY N/A
  • EPS Growth
  • PHAR N/A
  • SNCY N/A
  • EPS
  • PHAR N/A
  • SNCY 0.82
  • Revenue
  • PHAR $285,745,000.00
  • SNCY $1,060,877,000.00
  • Revenue This Year
  • PHAR $20.89
  • SNCY $4.23
  • Revenue Next Year
  • PHAR $11.15
  • SNCY $7.86
  • P/E Ratio
  • PHAR N/A
  • SNCY $18.24
  • Revenue Growth
  • PHAR 30.64
  • SNCY 2.87
  • 52 Week Low
  • PHAR $6.65
  • SNCY $9.22
  • 52 Week High
  • PHAR $13.20
  • SNCY $16.42
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 53.32
  • SNCY 57.88
  • Support Level
  • PHAR $8.71
  • SNCY $14.56
  • Resistance Level
  • PHAR $9.59
  • SNCY $15.44
  • Average True Range (ATR)
  • PHAR 0.33
  • SNCY 0.60
  • MACD
  • PHAR 0.11
  • SNCY 0.01
  • Stochastic Oscillator
  • PHAR 51.03
  • SNCY 67.12

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About SNCY Sun Country Airlines Holdings Inc.

Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.

Share on Social Networks: